Skip to content

The effect of flaxseed intoxication dose of Esketamine on the incidence of chronic pain after knee arthroplasty: a randomized controlled study

The effect of flaxseed intoxication dose of Esketamine on the incidence of chronic pain after knee arthroplasty

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075456
Enrollment
Unknown
Registered
2023-09-05
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic post-surgical pain after knee arthroplasty

Interventions

intervention group:During anesthesia induction, intravenous injection of 0.25mg/kg of Esketamine and continuous intravenous infusion of 0.125mg/(kg*h) of Esketamine during surgery
control group:During anesthesia induction, the same volume of physiological saline was injected intravenously as in the intervention group, and the same speed of physiological saline was continuously

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Meeting the diagnostic criteria of knee osteoarthritis; 2. Age =18years old; 3. BMI 18.5-30 kg/m^2 4. ASA grade I-III; 5. Undergoing the first unilateral total knee arthroplasty under elective general anesthesia.

Exclusion criteria

Exclusion criteria: 1. There are contraindications related to the use of Esketamine; 2. Previous history of knee joint injuries and surgeries; 3. Have rheumatic immune system diseases such as rheumatoid arthritis and systemic lupus erythematosus; 4. Have neuromuscular or psychiatric disorders; 5. Complication with severe cardiovascular, cerebrovascular, and pulmonary diseases or severe liver and kidney dysfunction before surgery; 6. Accompanied with cancerous pain; 7. Unable to understand or cooperate in completing relevant scales; 8. Refuse to sign an informed consent form or participate in other clinical trials at the same time.

Design outcomes

Primary

MeasureTime frame
The incidence of postoperative chronic pain;

Secondary

MeasureTime frame
Numerical Rating Scale;Western Ontario and McMaster Universities Osteoarthritis Index;Hospital Anxiety and Depression Scale;ID Pain Scale;

Countries

China

Contacts

Public ContactShen Wen

Affiliated Hospital of Xuzhou Medical University

shenwen670201@163.com+86 180 5226 8689

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026